李芋锦,胡晓梅.Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to[J].ANN HEMATOL.2020,99(6):1167-1176.doi:10.1007/s00277-020-04028-z.
APA:
李芋锦&胡晓梅.(2020).Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to.ANN HEMATOL,99,(6)
MLA:
李芋锦,et al."Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to".ANN HEMATOL 99..6(2020):1167-1176